FDA clears Withings' new blood pressure monitor

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Clears Withings' New Blood Pressure Monitor That Allows Providers to Communicate Directly with Patients This week, the FDA granted clearance to Withings' BPM Pro 2 cellular blood pressure monitor. The device seeks to help providers scale remote patient monitoring for heart failure patients. Sponsored Simplify Billing and Maximize Your Revenue Presented by Elation Health Get paid faster with Elation Health's unified EHR and Billing solution—offering 97.5% first-pass acceptance and an average 10-day payment time. "It's so straightforward—no guessing or endless clicks!"  Simplify billing and maximize your practice's revenue with ease today.  Learn more today. Speak at INVEST 2025! Are you a thought leader in healthcare innovation, investment, or entrepreneurship? Share your expertise with an audience of top investors, startups, and industry leaders at INVEST 2025, May 20-21 in Chicago. Deadline: Apply by January 10, 2025. Submit Your Application Now

Featured News

WellTheory Announces Women's Health Program to Address Hormonal Conditions WellTheory has launched a new program that will address the link between autoimmune disease and hormone imbalances. Teva and Sanofi Mid-Stage Data Reveal Shows Best-in-Class Potential for IBD Drug The Teva Pharmaceuticals and Sanofi drug, duvakitug, showed statistically significant and clinically meaningful results in a Phase 2b study in ulcerative colitis and Crohn's disease. The drug is part of an emerging class of therapies that target TL1A, a protein involved in signaling that drives inflammation. The Future of Men's Healthcare: A Path to Improved Access, Outcomes, and Cost Savings Telehealth empowers men to take control of their health in a way that is easy, confidential, and fits into their busy lifestyles. Let's Rethink AI — Patient Intake Is the Perfect Place to Start Solutions like AI-powered patient intake offer a tangible ROI by streamlining administrative tasks, reducing errors, and improving care quality.

Resources

SPONSORED MedCity Pivot Podcast: Self-insured Employers Weigh Benefits of GLP-1 Drugs In a conversation with MedCity News Editor-in-Chief Arundhati Parmar, Personify Health Chief Medical Officer Jeff Jacques talks about the different types of GLP-1 drugs, what portion of employers currently offer the medications, and how many employers are considering making them part of their health benefit offering in the future. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe